About this content. Alzheimer’s disease is the most common form of dementia, affecting more than 50 million people around the world. Its initial description by Alois Alzheimer in 1906 sparked a ...

Oct. 16, 2024 — Researchers used mouse models and human post-mortem brain tissue to study the molecular underpinnings that may increase the risk of Alzheimer's after ... Alzheimer's Disease May ...

Researchers say they have developed an Alzheimer's drug to prevent the build-up of toxic proteins in the brain. Proxima Studio - stock.adobe.com Researchers say they have sparked an “exciting ...

Alzheimer's disease is a progressive neurodegenerative disease that impairs memory and cognitive judgment and is often accompanied by mood swings, disorientation and eventually delirium. It is the ...

An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease. For the first time, scientists have developed a drug that works on ...

Studies have not found evidence that aluminum contributes to Alzheimer’s disease development. But research is ongoing, and you could be a part of it. Alzheimer’s is a progressive disease that ...

Scientists say they have achieved a "first" in the development of drugs to treat Alzheimer's disease. In a study published in the journal Alzheimer's & Dementia, a team of researchers report the ...

Whether $5 or $50, every contribution counts. Researchers have hailed a breakthrough in the development of drugs to treat Alzheimer’s. Scientists have created a drug that works by targeting both ...

Researchers do not believe Alzheimer’s disease has one specific cause. Instead, a combination of genetic, environmental, and lifestyle risk factors can contribute to the condition. Alzheimer’s ...

What Causes Alzheimer’s Disease? Researchers don't know exactly what causes Alzheimer’s disease. Many things are thought to be involved. But as scientists have learned more about the condition ...

The AHA has issued a new scientific statement on the link between three common cardiovascular diseases and the risk for cognitive impairment and dementia.

Medicare could save millions of dollars every year by changing the way they package Alzheimer's medication. Alzheimer's affects roughly 5.8 million Americans, according to the Centers for Disease ...